CARESCAPE
Model D19KT VER01 · GE Healthcare Finland Oy · DI 00840682118262
BZK — Spirometer, Monitoring (W/Wo Alarm) · Class II · 21 CFR 868.1850
BZL — Computer, Oxygen-Uptake · Class II · 21 CFR 868.1730
BZQ — Monitor, Breathing Frequency · Class II · 21 CFR 868.2375
CAP — Monitor, Airway Pressure (Includes Gauge And/Or Alarm) · Class II · 21 CFR 868.2600
CBQ — Analyzer, Gas, Enflurane, Gaseous-Phase (Anesthetic Concentration) · Class II · 21 CFR 868.1500
CBR — Analyzer, Gas, Nitrous-Oxide, Gaseous Phase (Anesthetic Conc.) · Class II · 21 CFR 868.1700
CBS — Analyzer, Gas, Halothane, Gaseous-Phase (Anesthetic Conc.) · Class II · 21 CFR 868.1620
CCK — Analyzer, Gas, Carbon-Dioxide, Gaseous-Phase · Class II · 21 CFR 868.1400
CCL — Analyzer, Gas, Oxygen, Gaseous-Phase · Class II · 21 CFR 868.1720
DPS — Electrocardiograph · Class II · 21 CFR 870.2340
DPZ — Oximeter, Ear · Class II · 21 CFR 870.2710
DQA — Oximeter · Class II · 21 CFR 870.2700
DQK — Computer, Diagnostic, Programmable · Class II · 21 CFR 870.1425
DRT — Monitor, Cardiac (Incl. Cardiotachometer & Rate Alarm) · Class II · 21 CFR 870.2300
DSI — Detector And Alarm, Arrhythmia · Class II · 21 CFR 870.1025
DSJ — Alarm, Blood-Pressure · Class II · 21 CFR 870.1100
DSK — Computer, Blood-Pressure · Class II · 21 CFR 870.1110
DXG — Computer, Diagnostic, Pre-Programmed, Single-Function · Class II · 21 CFR 870.1435
DXN — System, Measurement, Blood-Pressure, Non-Invasive · Class II · 21 CFR 870.1130
FLL — Continuous Measurement Thermometer · Class II · 21 CFR 880.2910
GWJ — Stimulator, Auditory, Evoked Response · Class II · 21 CFR 882.1900
GWQ — Full-Montage Standard Electroencephalograph · Class II · 21 CFR 882.1400
KOI — Stimulator, Nerve, Peripheral, Electric · Class II · 21 CFR 868.2775
KRB — Probe, Thermodilution · Class II · 21 CFR 870.1915
MHX — Monitor, Physiological, Patient(With Arrhythmia Detection Or Alarms) · Class II · 21 CFR 870.1025
MLD — Monitor, St Segment With Alarm · Class II · 21 CFR 870.1025
NHO — Analyzer, Gas, Desflurane, Gaseous-Phase (Anesthetic Concentration) · Class II · 21 CFR 868.1500
NHP — Analyzer, Gas, Sevoflurane, Gaseous-Phase (Anesthetic Concentration) · Class II · 21 CFR 868.1500
NHQ — Analyzer, Gas, Isoflurane, Gaseous-Phase (Anesthetic Concentration) · Class II · 21 CFR 868.1500
OLT — Non-Normalizing Quantitative Electroencephalograph Software · Class II · 21 CFR 882.1400
OLW — Index-Generating Electroencephalograph Software · Class II · 21 CFR 882.1400
OMC — Reduced- Montage Standard Electroencephalograph · Class II · 21 CFR 882.1400
ORT — Burst Suppression Detection Software For Electroencephalograph · Class II · 21 CFR 882.1400
UDILibrary device dossier · generated 2026-09-13 · sources: FDA GUDID, openFDA (recalls, MAUDE, 510(k)/PMA), FDA Data Dashboard (inspections, compliance actions), 510(k) summary documents.
Recall history (1)
| Initiated | Recall # | Class | Status | Reason | Link basis |
|---|---|---|---|---|---|
| 2024-04-05 | Z-2170-2024 | Class II | Open, Classified | GE HealthCare has become aware of the potential for loss of monitoring on CARESCAPE Canvas 1000, CARESCAPE Canvas Smart Display, and certain versions of CARESCAPE B850 and CARESCAPE B650 monitors if, following the replacement of the CPU timekeeper battery, a mains power loss occurs during active monitoring. In the unlikely event that this occurs, it can result in the displays or monitors not turning on, after the mains power is restored. This can result in a delay in recognizing changes in patient condition until a replacement monitor is connected. | k number procode |
Adverse-event reports — MAUDE (0)
Caveat (required reading): MAUDE report counts cannot be used to compute incidence rates or compare device safety. Reporting is incomplete, duplicated, and spikes with publicity; there is no denominator of devices in use. The peer line is a reporting baseline (average device in the same product code), not a risk measure.
| Month | This device (reports) | Product-code average (reports per device) |
|---|---|---|
| 2019-01 | 0 | 9.75 |
| 2019-02 | 0 | 8.22 |
| 2019-03 | 0 | 9.59 |
| 2019-04 | 0 | 7.07 |
| 2019-05 | 0 | 7.04 |
| 2019-06 | 0 | 6.51 |
| 2019-07 | 0 | 8.06 |
| 2019-08 | 0 | 7.12 |
| 2019-09 | 0 | 8.97 |
| 2019-10 | 0 | 7.78 |
| 2019-11 | 0 | 8.39 |
| 2019-12 | 0 | 7.81 |
| 2020-01 | 0 | 7.33 |
| 2020-02 | 0 | 7.89 |
| 2020-03 | 0 | 8.36 |
| 2020-04 | 0 | 8.22 |
| 2020-05 | 0 | 6.3 |
| 2020-06 | 0 | 6.7 |
| 2020-07 | 0 | 6.32 |
| 2020-08 | 0 | 7.47 |
| 2020-09 | 0 | 8.35 |
| 2020-10 | 0 | 7.89 |
| 2020-11 | 0 | 13.3 |
| 2020-12 | 0 | 15.56 |
| 2021-01 | 0 | 12.52 |
| 2021-02 | 0 | 8.84 |
| 2021-03 | 0 | 11.35 |
| 2021-04 | 0 | 9.62 |
| 2021-05 | 0 | 8.44 |
| 2021-06 | 0 | 8.89 |
| 2021-07 | 0 | 8.17 |
| 2021-08 | 0 | 9.04 |
| 2021-09 | 0 | 8.03 |
| 2021-10 | 0 | 7.18 |
| 2021-11 | 0 | 8.99 |
| 2021-12 | 0 | 9.18 |
| 2022-01 | 0 | 8.58 |
| 2022-02 | 0 | 8.7 |
| 2022-03 | 0 | 9.77 |
| 2022-04 | 0 | 8.77 |
| 2022-05 | 0 | 9.95 |
| 2022-06 | 0 | 7.11 |
| 2022-07 | 0 | 6.6 |
| 2022-08 | 0 | 8.11 |
| 2022-09 | 0 | 8.35 |
| 2022-10 | 0 | 10.33 |
| 2022-11 | 0 | 8.06 |
| 2022-12 | 0 | 8.62 |
| 2023-01 | 0 | 6.75 |
| 2023-02 | 0 | 11.33 |
| 2023-03 | 0 | 13.83 |
| 2023-04 | 0 | 12.87 |
| 2023-05 | 0 | 12.59 |
| 2023-06 | 0 | 10.3 |
| 2023-07 | 0 | 14.46 |
| 2023-08 | 0 | 15.6 |
| 2023-09 | 0 | 15.93 |
| 2023-10 | 0 | 10.54 |
| 2023-11 | 0 | 13.98 |
| 2023-12 | 0 | 13.53 |
| 2024-01 | 0 | 13.31 |
| 2024-02 | 0 | 13.04 |
| 2024-03 | 0 | 14.42 |
| 2024-04 | 0 | 8.89 |
| 2024-05 | 0 | 11.55 |
| 2024-06 | 0 | 10.11 |
| 2024-07 | 0 | 11.77 |
| 2024-08 | 0 | 11.34 |
| 2024-09 | 0 | 13.41 |
| 2024-10 | 0 | 16 |
| 2024-11 | 0 | 12.26 |
| 2024-12 | 0 | 11.03 |
| 2025-01 | 0 | 12.86 |
| 2025-02 | 0 | 10.14 |
| 2025-03 | 0 | 13.62 |
| 2025-04 | 0 | 9.52 |
| 2025-05 | 0 | 10.35 |
| 2025-06 | 0 | 7.83 |
| 2025-07 | 0 | 12 |
| 2025-08 | 0 | 8.31 |
| 2025-09 | 0 | 7.63 |
| 2025-10 | 0 | 11.4 |
| 2025-11 | 0 | 8.83 |
| 2025-12 | 0 | 9.36 |
| 2026-01 | 0 | 9.19 |
| 2026-02 | 0 | 10.78 |
| 2026-03 | 0 | 9.89 |
| 2026-04 | 0 | 14.83 |
| 2026-05 | 0 | 13.23 |
| 2026-06 | 0 | 11.59 |
Regulatory clearances
- K213336 SESE 2022-04-13 (k number procode)
Predicate lineage
K213336 — cites (transitively): K110028 (d1), K182868 (d1), K191323 (d1), K100428 (d2), K082327 (d2), K131414 (d2), K150245 (d2), K080238 (d3), K091241 (d3), K092027 (d3), K051092 (d3), K123195 (d3) — cited as predicate by K213518, K223531
Lineage extracted from public 510(k) summary text (heuristic).
Manufacturer compliance record — GE Healthcare Finland Oy
- VAI 2012-02-02 GE Healthcare Finland Oy · 1 citations